Li Zhili, Rahman Naimur, Bi Cheng, Mohallem Rodrigo, Pattnaik Aryamav, Kazemian Majid, Huang Fang, Aryal Uma K, Andrisani Ourania
Department of Basic Medical Sciences, Purdue University, West Lafayette, Indiana, USA.
Purdue Institute for Cancer Research, Purdue University, West Lafayette, Indiana, USA.
J Med Virol. 2024 Dec;96(12):e70118. doi: 10.1002/jmv.70118.
RNA helicase DDX5 is a host restriction factor for hepatitis B virus (HBV) biosynthesis. Mass spectrometry (LC-MS/MS) identified significant DDX5-interacting partners, including interferon-inducible protein 16 (IFI16) and RBBP4/7, an auxiliary subunit of polycomb repressive complex 2 (PRC2). DDX5 co-eluted with IFI16, RBBP4/7, and core PRC2 subunits in size exclusion chromatography fractions derived from native nuclear extracts. Native gel electrophoresis of DDX5 immunoprecipitants revealed a 750 kDa DDX5/IFI16/PRC2 complex, validated by nanoscale co-localization via super-resolution microscopy. Prior studies demonstrated that IFI16 suppresses HBV transcription by binding to the interferon-sensitive response element of covalently closed circular DNA (cccDNA), reducing H3 acetylation and increasing H3K27me3 levels by an unknown mechanism. Herein, we demonstrate that ectopic expression of IFI16 inhibited HBV transcription from recombinant rcccDNA, correlating with increased IFI16 binding to rcccDNA, reduced H3 acetylation, and elevated H3K27me3, determined by chromatin immunoprecipitation. Importantly, the inhibitory effect of ectopic IFI16 on HBV transcription was reversed by siRNA-mediated knockdown of DDX5 and EZH2, the methyltransferase subunit of PRC2. This reversal was associated with decreased IFI16 binding to rcccDNA, enhanced H3 acetylation, and reduced H3K27me3. Similarly, endogenous IFI16 induced by interferon-α inhibited HBV rcccDNA transcription in a DDX5- and PRC2-dependent manner. In HBV-infected HepG2-NTCP cells, the antiviral effect of interferon-α was abrogated upon knockdown of DDX5 and EZH2, underscoring the crucial role of the DDX5 complex in IFI16-mediated antiviral response. In conclusion, in response to interferon, DDX5 partners with IFI16 to bind cccDNA, directing PRC2 to epigenetically silence cccDNA chromatin, thereby regulating immune signaling and HBV transcription.
RNA解旋酶DDX5是乙型肝炎病毒(HBV)生物合成的宿主限制因子。质谱分析(液相色谱-串联质谱,LC-MS/MS)鉴定出了与DDX5相互作用的重要蛋白,包括干扰素诱导蛋白16(IFI16)以及多梳抑制复合体2(PRC2)的辅助亚基RBBP4/7。在源自天然核提取物的尺寸排阻色谱级分中,DDX5与IFI16、RBBP4/7以及PRC2核心亚基共同洗脱。对DDX5免疫沉淀产物进行的天然凝胶电泳显示存在一个750 kDa的DDX5/IFI16/PRC2复合体,通过超分辨率显微镜进行的纳米级共定位验证了这一复合体的存在。先前的研究表明,IFI16通过与共价闭合环状DNA(cccDNA)的干扰素敏感反应元件结合来抑制HBV转录,其通过未知机制降低H3乙酰化水平并提高H3K27me3水平。在此,我们证明IFI16的异位表达抑制了重组rcccDNA的HBV转录,这与IFI16与rcccDNA结合增加、H3乙酰化降低以及H3K27me3升高相关,这些结果通过染色质免疫沉淀法得以确定。重要的是,通过小干扰RNA(siRNA)介导敲低DDX5和PRC2的甲基转移酶亚基EZH2,可以逆转IFI16异位表达对HBV转录的抑制作用。这种逆转与IFI16与rcccDNA的结合减少、H3乙酰化增强以及H3K27me3降低有关。同样,干扰素-α诱导的内源性IFI16以依赖DDX5和PRC2的方式抑制HBV rcccDNA转录。在HBV感染的HepG2-NTCP细胞中,敲低DDX5和EZH2后,干扰素-α的抗病毒作用被消除,这突出了DDX5复合体在IFI16介导的抗病毒反应中的关键作用。总之,在对干扰素的反应中,DDX5与IFI16合作结合cccDNA,引导PRC2对cccDNA染色质进行表观遗传沉默,从而调节免疫信号和HBV转录。